Top Institutions in Oncology/Pathology
Leading institutions in colorectal cancer immunology and pathology have conducted large-scale international validation studies of the Immunoscore, integrating immune profiling with clinical outcomes to refine risk stratification and optimize treatment strategies.
-
#100
INSERM (French National Institute of Health and Medical Research)
Paris, Île-de-France
INSERM researchers pioneered the development and international validation of the Immunoscore assay, leading large multicenter studies that established its prognostic value in colorectal cancer.
Key Differentiators
- Oncology
- Immunology
- Pathology
-
#85
The University of Hong Kong, School of Clinical Medicine
Hong Kong, Hong Kong SAR
Active contributors to Immunoscore research with clinical pathology expertise, focusing on integrating Immunoscore into routine colorectal cancer diagnostics and treatment guidance.
Key Differentiators
- Pathology
- Oncology
-
#80
Memorial Sloan Kettering Cancer Center
New York, NY
Leading cancer center with extensive research in colorectal cancer immunology and clinical trials incorporating immune biomarkers like Immunoscore to guide therapy.
Key Differentiators
- Oncology
- Surgical Oncology
- Immunotherapy
-
#75
MD Anderson Cancer Center
Houston, TX
Renowned for immuno-oncology research and integrating immune profiling assays such as Immunoscore into clinical practice for colorectal cancer management.
Key Differentiators
- Oncology
- Immunotherapy
- Pathology
-
#70
Institut Gustave Roussy
Villejuif, Île-de-France
Major European cancer center involved in Immunoscore validation studies and advancing immune-based prognostic tools in colorectal cancer.
Key Differentiators
- Oncology
- Immunology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
